What Are Your Treatment Options?

The key to minimizing or eliminating Long Covid symptoms is to target the biomarkers that are responsible for causing vascular inflammation.

Vascular inflammation occurs when specific white blood cells with Covid proteins migrate throughout the body releasing pro-inflammatory cytokines and chemokines to signal more inflammation.

One of these chemokines is CCR5 and is secreted by both the immune and endothelial cells. Another is called fractalkine which acts like Velcro causing the specific white blood cells to stick to the endothelial cells that line blood vessels.

Successful treatment of Long Covid requires the prevention of these specific white blood cells from migrating to other parts of the body by blocking the effects of CCR5 and fractalkine cytokines.

Fortunately, there are two prescription therapeutics that when used in combination, frequently accomplish this objective.

Maraviroc (CCR5 antagonist) and Pravastatin (fractalkine inhibitor) are both commercially available.

These therapeutics were investigated and published in a paper entitled “Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC). This study link is below for your reference: (CLICK HERE FOR STUDY PAPER)

In a recent Harvard study 3,925 patients were surveyed regarding the effectiveness of 150 Long Covid treatments. The therapeutic that received the highest ranking was Maraviroc. This study link is below for your reference: (CLICK HERE FOR STUDY PAPER)